# Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)

> **NCT06454890** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Henan Cancer Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer NSCLC

## Interventions

- **BIOLOGICAL:** Anti-Trop2 CAR-NK cell

## Key facts

- **NCT ID:** NCT06454890
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2029-07-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454890, "Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06454890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*